TipRanks
Advertisement
Advertisement

DE:DR6 Stock Latest News

Acadia Pharmaceuticals announces USPTO allowance of patent covering Trofinetide
The FlyAcadia Pharmaceuticals announces USPTO allowance of patent covering Trofinetide
6d ago
ACAD
Acadia price target lowered to $33 from $37 at H.C. Wainwright
PremiumThe Fly
Acadia price target lowered to $33 from $37 at H.C. Wainwright
9d ago
ACAD
Acadia Pharmaceuticals price target lowered to $35 from $41 at Needham
PremiumThe Fly
Acadia Pharmaceuticals price target lowered to $35 from $41 at Needham
9d ago
ACAD
Acadia Pharmaceuticals price target lowered to $31 from $38 at Deutsche Bank
PremiumThe Fly
Acadia Pharmaceuticals price target lowered to $31 from $38 at Deutsche Bank
9d ago
ACAD
Acadia Pharmaceuticals price target lowered to $34 from $36 at BMO Capital
PremiumThe Fly
Acadia Pharmaceuticals price target lowered to $34 from $36 at BMO Capital
9d ago
ACAD
Acadia Pharmaceuticals price target lowered to $33 from $36 at Citizens
PremiumThe FlyAcadia Pharmaceuticals price target lowered to $33 from $36 at Citizens
9d ago
ACAD
Acadia Reports Phase 2 Data for Alzheimer’s Psychosis
Premium
Company Announcements
Acadia Reports Phase 2 Data for Alzheimer’s Psychosis
10d ago
8K
ACAD
Acadia Pharmaceuticals price target lowered to $33 from $40 at Citi
Premium
The Fly
Acadia Pharmaceuticals price target lowered to $33 from $40 at Citi
10d ago
ACAD
Acadia Pharmaceuticals falls -10.2%
PremiumThe Fly
Acadia Pharmaceuticals falls -10.2%
10d ago
ACAD
Morning Movers: Stitch Fix plunges as earnings report, outlook disappoints
PremiumThe Fly
Morning Movers: Stitch Fix plunges as earnings report, outlook disappoints
10d ago
P
BB
Acadia Pharmaceuticals down 6% at $23.93 after update on Phase 2 RADIANT trial
PremiumThe Fly
Acadia Pharmaceuticals down 6% at $23.93 after update on Phase 2 RADIANT trial
10d ago
ACAD
Acadia says Phase 2 portion of RADIANT trial ‘narrowly missed’ primary endpoint
PremiumThe Fly
Acadia says Phase 2 portion of RADIANT trial ‘narrowly missed’ primary endpoint
10d ago
ACAD
Acadia Pharmaceuticals Reaches Preliminary Derivative Lawsuit Settlement
PremiumCompany AnnouncementsAcadia Pharmaceuticals Reaches Preliminary Derivative Lawsuit Settlement
23d ago
8K
ACAD
Acadia Pharmaceuticals price target raised to $38 from $37 at Deutsche Bank
Premium
The Fly
Acadia Pharmaceuticals price target raised to $38 from $37 at Deutsche Bank
1M ago
ACAD
ACADIA: EU Orphan Drug Launch Underscores Pricing Strength; Buy Rating and $37 Price Target Reaffirmed
Premium
Ratings
ACADIA: EU Orphan Drug Launch Underscores Pricing Strength; Buy Rating and $37 Price Target Reaffirmed
1M ago
ACAD
ACADIA: Buy Rating Reiterated as Daybue Momentum Builds and Key Pipeline Catalyst Nears; Price Target Maintained at $36
PremiumRatings
ACADIA: Buy Rating Reiterated as Daybue Momentum Builds and Key Pipeline Catalyst Nears; Price Target Maintained at $36
1M ago
ACAD
Acadia Pharmaceuticals price target raised to $28 from $27 at Morgan Stanley
PremiumThe Fly
Acadia Pharmaceuticals price target raised to $28 from $27 at Morgan Stanley
1M ago
ACAD
Analyst Lifts ACADIA Price Target to $40 on Favorable Risk‑Reward and RADIANT Alzheimer’s Psychosis Upside
PremiumRatings
Analyst Lifts ACADIA Price Target to $40 on Favorable Risk‑Reward and RADIANT Alzheimer’s Psychosis Upside
1M ago
ACAD
Acadia Pharmaceuticals price target raised to $40 from $39 at Citi
PremiumThe Fly
Acadia Pharmaceuticals price target raised to $40 from $39 at Citi
1M ago
ACAD
Acadia Pharmaceuticals announces EC marketing authorization for Daybu
PremiumThe FlyAcadia Pharmaceuticals announces EC marketing authorization for Daybu
1M ago
ACAD
Acadia Pharmaceuticals price target raised to $49 from $45 at UBS
Premium
The Fly
Acadia Pharmaceuticals price target raised to $49 from $45 at UBS
2M ago
ACAD
Acadia Pharmaceuticals price target raised to $41 from $38 at Needham
Premium
The Fly
Acadia Pharmaceuticals price target raised to $41 from $38 at Needham
2M ago
ACAD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >